Characteristics, clinical benefit, and reimbursement of new authorisations for oncohaematology drugs in Spain between 2017 and 2020 Martinez-Barros, Álvaro Pousada-Fonseca, Jorge Pedreira-Bouzas, Clopes-Estela

Matching-Adjusted Indirect Comparisons in the assessment of hemato-oncological drugs José Manuel Martínez-Sesmero, Javier De Castro-Carpeño, Araceli López-de las Heras, Alonso Fernández-Nistal, Francisco Javier Parrondo-García

Assessment of new drugs in a tertiary hospital using a standardized tool J. González-Bueno, E. Chamorro-de-Vega, E.R. Alfaro-Lara, M. Galván-Banqueri, B. Santos-Ramos